TARO-MELPHALAN DIN 02480026
Status: Marketed
Holder: TARO PHARMACEUTICALS INC
Molecule: MELPHALAN (MELPHALAN HYDROCHLORIDE)
Available to quote
Health Canada record
| Active ingredient(s) | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG; BUFFER SOLUTION 10 ML |
|---|---|
| Dosage form | Kit; Powder For Solution |
| Route | Intravenous; Intra-Arterial |
| Schedule | PRESCRIPTION |
| Class | Human |
| ATC | L01AA03 MELPHALAN |
| Original market date | 25-Jan-2021 |
| Current status date | 25-Jan-2021 |
| Source | Health Canada DPD |
Establishment licence of the holder
Taro Pharmaceuticals Inc — licence 100232, not currently licensed, last inspection rating C (2025-03-24).
No Canadian shortage report is currently matched to this DIN.
Other Canadian products containing MELPHALAN (MELPHALAN HYDROCHLORIDE)
| DIN | Product | Company | Form | Strength | Status |
|---|---|---|---|---|---|
| 02087286 | ALKERAN | ASPEN PHARMACARE CANADA INC. | Powder For Solution; Solution; Kit | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG; BUFFER SOLUTION 10 ML | Marketed |
| 02473348 | MELPHALAN FOR INJECTION | MARCAN PHARMACEUTICALS INC | Powder For Solution; Solution; Kit | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG; BUFFER SOLUTION 10 ML | Marketed |
| 02508214 | MELPHALAN FOR INJECTION | AURO PHARMA INC | Powder For Solution; Kit | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG | Approved |
| 02537389 | MELPHALAN FOR INJECTION | EUGIA PHARMA INC. | Powder For Solution; Kit | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG | Approved |
| 02468921 | MELPHALAN FOR INJECTION | APOTEX INC | Powder For Solution; Kit; Solution | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG; BUFFER SOLUTION 10 ML | Dormant |
| 02526077 | MELPHALAN FOR INJECTION | JUNO PHARMACEUTICALS CORP. | Kit; Powder For Solution | MELPHALAN (MELPHALAN HYDROCHLORIDE) 50 MG | Cancelled Pre Market |
Notices of Compliance
| NOC | Date | Submission | Reason |
|---|---|---|---|
| 21201 | 2018-08-10 | Abbreviated New Drug Submission (ANDS) |